Jurilab will use data from a genetic screening project involving an isolated population in
The companies will collaborate to validate the diabetes associations of these markers in populations outside
Nanogen plans to develop diagnostic tests for panels of confirmed markers, and the companies will jointly seek pharmaceutical partners to develop therapeutics based on genes determined to play a role in the disease.